Synapse - Adult Leukemia

Results (3720)

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

Journal Article

Rafiq, S.; Purdon, T. J.; Daniyan, A. F.; Koneru, M.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
Leukemia (2017)

Fulltext@MSK | Save

Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy

Journal Article

Abla, O.; Ribeiro, R. C.; Testi, A. M.; Montesinos, P.; Creutzig, U.; Sung, L.; Di Giuseppe, G.; Stephens, D.; Feusner, J. H.; Powell, B. L.; more...
Annals of Hematology (2017)

Fulltext@MSK | Save

Real-world treatment patterns and costs in medicare beneficiaries newly diagnosed with acute myeloid leukemia

Meeting Abstract

Stein, E. M.; Latremouille-Viau, D.; Guerin, A.; Shi, S.; Gagnon-Sanschagrin, P.; Briggs, O.; Bonifacio, G.; Joseph, G.
Value in Health (2017)

Fulltext@MSK | Save

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States

Meeting Abstract

Stein, E. M.; Yang, M.; Gao, W.; Galebach, P.; Xiang, C. Q.; Bhattacharyya, S.; Bonifacio, G.; Joseph, G. J.
Value in Health (2017)

Fulltext@MSK | Save

Phase I trial of alpha-particle immunotherapy with (225)Ac-lintuzumab and low-dose cytarabine in patients age 60 or older with untreated acute myeloid leukemia

Meeting Abstract

Jurcic, J.; Levy, M.; Park, J.; Ravandi, F.; Perl, A.; Pagel, J.; Smith, B.; Orozco, J.; Estey, E.; Kantarjian, H.; more...
Journal of Nuclear Medicine (2017)

Fulltext@MSK | Save

Pooled survival analysis of midostaurin clinical study data (D2201+A2213) in patients with advanced systemic mastocytosis compared with historical controls

Meeting Abstract

Reiter, A.; Kluin-Nelemans, H. C.; George, T.; Akin, C.; DeAngelo, D. J.; Hermine, O.; Awan, F.; Hexner, E.; Mauro, M.; Schwaab, J.; more...
Haematologica (2017)

Fulltext@MSK | Save

Analysis of dasatinib and imatinib 5-year efficacy and safety based on baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) in DASISION

Meeting Abstract

Saglio, G.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E. L.; Abaskharoun, M.; Li, L.; Mauro, M. J.
Haematologica (2017)

Fulltext@MSK | Save

Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy

Meeting Abstract

Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
Haematologica (2017)

Fulltext@MSK | Save

Variant FLT3 mutations can be eradicated by cytarabine/anthracycline/crenolanib induction in adult patients with newly diagnosed FLT3 (ITK/TKD) mutant AML

Meeting Abstract

Wang, E.; Stone, R.; Collins, R.; Agrawal, T.; Urity, V.; Tallman, M.
Haematologica (2017)

Fulltext@MSK | Save

Patients with acute myeloid leukemia who have mutations in IDH1 or IDH2 respond well to induction chemotherapy with "7+3" despite the presence of complex karyotype or FLT3-ITD

Meeting Abstract

Gupta, D. M.; Devlin, D. S.; Tallman, D. M.; Stein, D. E.
Haematologica (2017)

Fulltext@MSK | Save